Eritrea vs Georgia: Tuberculosis patients living with HIV receiving antiretroviral therapy
Eritrea
41 patients
in 2021
Georgia
43 patients
in 2021
Eritrea rank
90th
Georgia rank
89th
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Eritrea
- Georgia
How they compare
Georgia currently reports 43 patients against 41 patients in Eritrea, a difference of 2 patients.
The two have swapped places 2 times across 10 shared years of data; in 2012 it was Georgia ahead.
Eritrea ranks 90th and Georgia ranks 89th of 183 countries.
Eritrea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Eritrea | Georgia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 75.25 patients | 48.25 patients | 27 patients | Eritrea |
| 2020s | 49 patients | 36 patients | 13 patients | Eritrea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Eritrea or Georgia?
- Georgia, at 43 patients against 41 patients in Eritrea as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Eritrea and Georgia?
- 2 patients, with Georgia ahead.
- How many years of comparable data are there for Eritrea and Georgia?
- 10 years are reported by both, from 2012 to 2021.
- How do Eritrea and Georgia rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Eritrea ranks 90th and Georgia ranks 89th of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.